|
Market Closed -
London S.E.
11:35:20 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 1,842.50 GBX | +0.85% |
|
-3.61% | +0.99% |
Company Valuation: GSK plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,458 | 58,381 | 59,112 | 54,944 | 73,201 | 73,865 | - | - |
| Change | - | -27.44% | 1.25% | -7.05% | 33.23% | 0.91% | - | - |
| Enterprise Value (EV) 1 | 100,296 | 75,578 | 74,152 | 68,039 | 87,654 | 95,756 | 93,042 | 90,376 |
| Change | - | -24.65% | -1.89% | -8.24% | 28.83% | 9.24% | -2.83% | -2.87% |
| P/E | 18.6x | 3.93x | 11.9x | 21.3x | 12.9x | 14.9x | 11.9x | 11x |
| PBR | 5.34x | 5.47x | 4.4x | 4.02x | 4.51x | 4.24x | 4.11x | 3.54x |
| PEG | - | 0x | -0.2x | -0.4x | 0x | -1.2x | 0.5x | 1.3x |
| Capitalization / Revenue | 2.36x | 1.99x | 1.95x | 1.75x | 2.24x | 2.18x | 2.09x | 2.03x |
| EV / Revenue | 2.94x | 2.58x | 2.45x | 2.17x | 2.68x | 2.83x | 2.64x | 2.48x |
| EV / EBITDA | 8.85x | 7.23x | 6.37x | 6.36x | 7.77x | 8.31x | 7.6x | 7.18x |
| EV / EBIT | 11.4x | 9.27x | 8.44x | 7.44x | 8.96x | 9.25x | 8.48x | 7.88x |
| EV / FCF | 22.6x | 12.1x | 13.6x | 13x | 13.7x | 20x | 19.7x | 15.4x |
| FCF Yield | 4.42% | 8.28% | 7.36% | 7.67% | 7.32% | 4.99% | 5.07% | 6.49% |
| Dividend per Share 2 | 1 | 0.6125 | 0.58 | 0.61 | 0.66 | 0.6958 | 0.7479 | 0.7822 |
| Rate of return | 4.98% | 4.26% | 4% | 4.53% | 3.62% | 3.78% | 4.06% | 4.25% |
| EPS 2 | 1.082 | 3.662 | 1.216 | 0.632 | 1.411 | 1.233 | 1.543 | 1.674 |
| Distribution rate | 92.4% | 16.7% | 47.7% | 96.5% | 46.8% | 56.4% | 48.5% | 46.7% |
| Net sales 1 | 34,114 | 29,324 | 30,328 | 31,376 | 32,667 | 33,833 | 35,276 | 36,462 |
| EBITDA 1 | 11,330 | 10,449 | 11,635 | 10,693 | 11,278 | 11,526 | 12,248 | 12,592 |
| EBIT 1 | 8,806 | 8,151 | 8,786 | 9,148 | 9,783 | 10,348 | 10,973 | 11,465 |
| Net income 1 | 4,385 | 14,956 | 4,928 | 2,575 | 5,716 | 4,918 | 6,109 | 6,668 |
| Net Debt 1 | 19,838 | 17,197 | 15,040 | 13,095 | 14,453 | 21,891 | 19,177 | 16,511 |
| Reference price 2 | 20.08 | 14.38 | 14.50 | 13.46 | 18.24 | 18.42 | 18.42 | 18.42 |
| Nbr of stocks (in thousands) | 4,006,383 | 4,060,999 | 4,076,145 | 4,080,519 | 4,012,126 | 4,008,939 | - | - |
| Announcement Date | 2/9/22 | 2/1/23 | 1/31/24 | 2/5/25 | 2/4/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.94x | 2.83x | 8.31x | 3.78% | 96.76B | ||
| 39.41x | 13.36x | 28.32x | 0.51% | 1,200B | ||
| 36.94x | 6.65x | 18.71x | 1.97% | 651B | ||
| 36.49x | 8.39x | 17.36x | 2.41% | 506B | ||
| 21.41x | 5.17x | 12.95x | 2.53% | 377B | ||
| 94.91x | 5.47x | 23.3x | 2.54% | 330B | ||
| 22.98x | 5.56x | 13.52x | 2.87% | 288B | ||
| 23.04x | 4.63x | 13.15x | 1.9% | 272B | ||
| 22.49x | 6.97x | 12.81x | 2.32% | 236B | ||
| -39.14x | 7.25x | 45.66x | 1.98% | 206B | ||
| Average | 27.35x | 6.63x | 19.41x | 2.28% | 416B | |
| Weighted average by Cap. | 33.80x | 8.32x | 21.20x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GSK Stock
- Valuation GSK plc
Select your edition
All financial news and data tailored to specific country editions
















